IJC is immersed in a strategic collaboration with the United Arab Emirates (UAE) in order to generate a stable alliance around liquid cancer research. In this sense, we already have several collaboration contracts signed with the main biohealth research entities in the UAE.



We are currently in the process of setting up a new start-up dedicated exclusively to this area and this trip is necessary to give it the definitive boost to consolidate the value proposition and the alliances described previously.



The trip will take place within the framework of a specific congress, the “Precision Med Exhibition & Summit” (https://precisionmedexpo.com/) but will be accompanied by a complete agenda of meetings that include everything from the UAE Ministry of Health to the country's leading biomedical research centers and hospitals. A meeting with local representatives of ACCIÓ and the Spanish Embassy in the Emirates is also planned.



The context of the trip therefore falls especially in an area of ​​innovation and transfer at an international level, with the promotion of the creation of a new company and the establishment of a knowledge transfer framework in the form of advice and co-creation of new personalized medicine platforms that will clearly benefit Catalan biomedical research by providing it with disruptive technologies, access to new patients and new high-value clinical data, and offering international visibility and reputation of high strategic value.